Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 104

    1.

    Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes.

    Jaeckel E, von Boehmer H, Manns MP.

    Diabetes. 2005 Feb;54(2):306-10. Epub 2004 Dec 10.PMID: 15591438 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction.

    Peng J, Dicker B, Du W, Tang F, Nguyen P, Geiger T, Wong FS, Wen L.

    J Autoimmun. 2007 Jun;28(4):188-200. Epub 2007 Apr 6.PMID: 17412560 [PubMed - indexed for MEDLINE]Related articles

    3.

    Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.

    Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA.

    Diabetes. 2008 Jan;57(1):113-23. Epub 2007 Oct 10.PMID: 17928397 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Foxp3-expressing CD4(+)T cells under the control of INF-gamma promoter prevent diabetes in NOD mice.

    Wang R, Han G, Wang J, Song L, Chen G, Xu R, Yu M, Qian J, Shen B, Li Y.

    Mol Ther. 2007 Aug;15(8):1551-7. Epub 2007 May 29.PMID: 17534268 [PubMed - indexed for MEDLINE]Related articles

    5.

    TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes.

    Peng Y, Laouar Y, Li MO, Green EA, Flavell RA.

    Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4572-7. Epub 2004 Mar 18.PMID: 15070759 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.

    Pallandre JR, Brillard E, Créhange G, Radlovic A, Remy-Martin JP, Saas P, Rohrlich PS, Pivot X, Ling X, Tiberghien P, Borg C.

    J Immunol. 2007 Dec 1;179(11):7593-604.PMID: 18025205 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.

    Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R.

    J Exp Med. 2005 Apr 18;201(8):1333-46.PMID: 15837817 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance.

    Chai JG, Xue SA, Coe D, Addey C, Bartok I, Scott D, Simpson E, Stauss HJ, Hori S, Sakaguchi S, Dyson J.

    Transplantation. 2005 May 27;79(10):1310-6.PMID: 15912097 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.

    Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A.

    Vaccine. 2006 Jun 5;24(23):5036-46. Epub 2006 Mar 31. Erratum in: Vaccine. 2007 Jan 4;25(2):399. PMID: 16621191 [PubMed - indexed for MEDLINE]Related articles

    11.

    Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.

    Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM, Suthanthiran M.

    Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2821-6. Epub 2007 Feb 16.PMID: 17307871 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.

    Albert MH, Liu Y, Anasetti C, Yu XZ.

    Eur J Immunol. 2005 Sep;35(9):2598-607.PMID: 16078276 [PubMed - indexed for MEDLINE]Related articles

    13.

    The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.

    Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R.

    Diabetes. 2007 May;56(5):1395-402. Epub 2007 Feb 22.PMID: 17317763 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.

    Mellanby RJ, Thomas D, Phillips JM, Cooke A.

    Immunology. 2007 May;121(1):15-28.PMID: 17428252 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.

    Sugimoto N, Oida T, Hirota K, Nakamura K, Nomura T, Uchiyama T, Sakaguchi S.

    Int Immunol. 2006 Aug;18(8):1197-209. Epub 2006 Jun 13.PMID: 16772372 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

    Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C.

    Diabetologia. 2009 Jul;52(7):1391-9. Epub 2009 May 7.PMID: 19421731 [PubMed - indexed for MEDLINE]Related articles

    17.

    Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3.

    Hong J, Li N, Zhang X, Zheng B, Zhang JZ.

    Proc Natl Acad Sci U S A. 2005 May 3;102(18):6449-54. Epub 2005 Apr 25.PMID: 15851684 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

    Exp Hematol. 2007 Mar;35(3):416-25.PMID: 17309822 [PubMed - indexed for MEDLINE]Related articles

    19.

    Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo.

    Weber SE, Harbertson J, Godebu E, Mros GA, Padrick RC, Carson BD, Ziegler SF, Bradley LM.

    J Immunol. 2006 Apr 15;176(8):4730-9.PMID: 16585566 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes.

    Wang R, Song L, Han G, Wang J, Chen G, Xu R, Yu M, Qian J, Shen B, Li Y.

    Scand J Immunol. 2007 Nov;66(5):515-22. Epub 2007 Sep 20.PMID: 17883389 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data